MedTrace Logo

Short-term Automated Longitudinal Analysis of Speech and Language in Cognitive Impairment

NCT05340218 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 196

Last updated 2026-03-25

No results posted yet for this study

Summary

Validate speech analysis AI models:

* To contrast the accuracy of acceXible's platform as a screening tool in the detection of people with cognitive impairment and mild dementia.
* To evaluate the correlation between automatically analyzed linguistic variables and a combination of standard measures of cognition.
* To assess short-term variability in language ability among older adults, and to assess which aspects of language vary during the study period.

Conditions

Interventions

OTHER

Speech analysis

Speech analysis to detect and monitor mild cognitive impairment

Sponsors & Collaborators

  • Accexible

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2022-03-22
Completion
2022-03-22

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05340218 on ClinicalTrials.gov